Large Molecule Injectable Drugs Market - Global Outlook and Forecast 2023-2028

Report ID: 1377102 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Large Molecule Injectable Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Large Molecule Injectable Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Large Molecule Injectable Drugs Overall Market Size
    2.1 Global Large Molecule Injectable Drugs Market Size: 2021 VS 2028
    2.2 Global Large Molecule Injectable Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Large Molecule Injectable Drugs Players in Global Market
    3.2 Top Global Large Molecule Injectable Drugs Companies Ranked by Revenue
    3.3 Global Large Molecule Injectable Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Large Molecule Injectable Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Large Molecule Injectable Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Large Molecule Injectable Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Large Molecule Injectable Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Large Molecule Injectable Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Large Molecule Injectable Drugs Market Size Markets, 2021 & 2028
        4.1.2 Intravenous Injection
        4.1.3 Muscle Injection
        4.1.4 Subcutaneous Injection
    4.2 By Type - Global Large Molecule Injectable Drugs Revenue & Forecasts
        4.2.1 By Type - Global Large Molecule Injectable Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Large Molecule Injectable Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Large Molecule Injectable Drugs Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global Large Molecule Injectable Drugs Revenue & Forecasts
        5.2.1 By Application - Global Large Molecule Injectable Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Large Molecule Injectable Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Large Molecule Injectable Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Large Molecule Injectable Drugs Revenue & Forecasts
        6.2.1 By Region - Global Large Molecule Injectable Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Large Molecule Injectable Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Large Molecule Injectable Drugs Revenue, 2017-2028
        6.3.2 US Large Molecule Injectable Drugs Market Size, 2017-2028
        6.3.3 Canada Large Molecule Injectable Drugs Market Size, 2017-2028
        6.3.4 Mexico Large Molecule Injectable Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Large Molecule Injectable Drugs Revenue, 2017-2028
        6.4.2 Germany Large Molecule Injectable Drugs Market Size, 2017-2028
        6.4.3 France Large Molecule Injectable Drugs Market Size, 2017-2028
        6.4.4 U.K. Large Molecule Injectable Drugs Market Size, 2017-2028
        6.4.5 Italy Large Molecule Injectable Drugs Market Size, 2017-2028
        6.4.6 Russia Large Molecule Injectable Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Large Molecule Injectable Drugs Market Size, 2017-2028
        6.4.8 Benelux Large Molecule Injectable Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Large Molecule Injectable Drugs Revenue, 2017-2028
        6.5.2 China Large Molecule Injectable Drugs Market Size, 2017-2028
        6.5.3 Japan Large Molecule Injectable Drugs Market Size, 2017-2028
        6.5.4 South Korea Large Molecule Injectable Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Large Molecule Injectable Drugs Market Size, 2017-2028
        6.5.6 India Large Molecule Injectable Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Large Molecule Injectable Drugs Revenue, 2017-2028
        6.6.2 Brazil Large Molecule Injectable Drugs Market Size, 2017-2028
        6.6.3 Argentina Large Molecule Injectable Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Large Molecule Injectable Drugs Revenue, 2017-2028
        6.7.2 Turkey Large Molecule Injectable Drugs Market Size, 2017-2028
        6.7.3 Israel Large Molecule Injectable Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Large Molecule Injectable Drugs Market Size, 2017-2028
        6.7.5 UAE Large Molecule Injectable Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 Biogen
        7.1.1 Biogen Corporate Summary
        7.1.2 Biogen Business Overview
        7.1.3 Biogen Large Molecule Injectable Drugs Major Product Offerings
        7.1.4 Biogen Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
        7.1.5 Biogen Key News
    7.2 AstraZeneca
        7.2.1 AstraZeneca Corporate Summary
        7.2.2 AstraZeneca Business Overview
        7.2.3 AstraZeneca Large Molecule Injectable Drugs Major Product Offerings
        7.2.4 AstraZeneca Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
        7.2.5 AstraZeneca Key News
    7.3 Roche
        7.3.1 Roche Corporate Summary
        7.3.2 Roche Business Overview
        7.3.3 Roche Large Molecule Injectable Drugs Major Product Offerings
        7.3.4 Roche Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
        7.3.5 Roche Key News
    7.4 Sun Pharmaceutical
        7.4.1 Sun Pharmaceutical Corporate Summary
        7.4.2 Sun Pharmaceutical Business Overview
        7.4.3 Sun Pharmaceutical Large Molecule Injectable Drugs Major Product Offerings
        7.4.4 Sun Pharmaceutical Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
        7.4.5 Sun Pharmaceutical Key News
    7.5 Medtronic
        7.5.1 Medtronic Corporate Summary
        7.5.2 Medtronic Business Overview
        7.5.3 Medtronic Large Molecule Injectable Drugs Major Product Offerings
        7.5.4 Medtronic Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
        7.5.5 Medtronic Key News
    7.6 Novartis
        7.6.1 Novartis Corporate Summary
        7.6.2 Novartis Business Overview
        7.6.3 Novartis Large Molecule Injectable Drugs Major Product Offerings
        7.6.4 Novartis Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
        7.6.5 Novartis Key News
    7.7 ​​Baxter
        7.7.1 ​​Baxter Corporate Summary
        7.7.2 ​​Baxter Business Overview
        7.7.3 ​​Baxter Large Molecule Injectable Drugs Major Product Offerings
        7.7.4 ​​Baxter Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
        7.7.5 ​​Baxter Key News
    7.8 Amgen
        7.8.1 Amgen Corporate Summary
        7.8.2 Amgen Business Overview
        7.8.3 Amgen Large Molecule Injectable Drugs Major Product Offerings
        7.8.4 Amgen Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
        7.8.5 Amgen Key News
    7.9 Pfizer
        7.9.1 Pfizer Corporate Summary
        7.9.2 Pfizer Business Overview
        7.9.3 Pfizer Large Molecule Injectable Drugs Major Product Offerings
        7.9.4 Pfizer Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
        7.9.5 Pfizer Key News
    7.10 Johnson & Johnson
        7.10.1 Johnson & Johnson Corporate Summary
        7.10.2 Johnson & Johnson Business Overview
        7.10.3 Johnson & Johnson Large Molecule Injectable Drugs Major Product Offerings
        7.10.4 Johnson & Johnson Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
        7.10.5 Johnson & Johnson Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Large Molecule Injectable Drugs Market Opportunities & Trends in Global Market
    Table 2. Large Molecule Injectable Drugs Market Drivers in Global Market
    Table 3. Large Molecule Injectable Drugs Market Restraints in Global Market
    Table 4. Key Players of Large Molecule Injectable Drugs in Global Market
    Table 5. Top Large Molecule Injectable Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Large Molecule Injectable Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Large Molecule Injectable Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Large Molecule Injectable Drugs Product Type
    Table 9. List of Global Tier 1 Large Molecule Injectable Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Large Molecule Injectable Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Large Molecule Injectable Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Large Molecule Injectable Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Large Molecule Injectable Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Large Molecule Injectable Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Large Molecule Injectable Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Large Molecule Injectable Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Large Molecule Injectable Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Large Molecule Injectable Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Large Molecule Injectable Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Large Molecule Injectable Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Large Molecule Injectable Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Large Molecule Injectable Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Large Molecule Injectable Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Biogen Corporate Summary
    Table 31. Biogen Large Molecule Injectable Drugs Product Offerings
    Table 32. Biogen Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. AstraZeneca Corporate Summary
    Table 34. AstraZeneca Large Molecule Injectable Drugs Product Offerings
    Table 35. AstraZeneca Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Roche Corporate Summary
    Table 37. Roche Large Molecule Injectable Drugs Product Offerings
    Table 38. Roche Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Sun Pharmaceutical Corporate Summary
    Table 40. Sun Pharmaceutical Large Molecule Injectable Drugs Product Offerings
    Table 41. Sun Pharmaceutical Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Medtronic Corporate Summary
    Table 43. Medtronic Large Molecule Injectable Drugs Product Offerings
    Table 44. Medtronic Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Novartis Corporate Summary
    Table 46. Novartis Large Molecule Injectable Drugs Product Offerings
    Table 47. Novartis Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. ​​Baxter Corporate Summary
    Table 49. ​​Baxter Large Molecule Injectable Drugs Product Offerings
    Table 50. ​​Baxter Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Amgen Corporate Summary
    Table 52. Amgen Large Molecule Injectable Drugs Product Offerings
    Table 53. Amgen Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Pfizer Corporate Summary
    Table 55. Pfizer Large Molecule Injectable Drugs Product Offerings
    Table 56. Pfizer Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Johnson & Johnson Corporate Summary
    Table 58. Johnson & Johnson Large Molecule Injectable Drugs Product Offerings
    Table 59. Johnson & Johnson Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Large Molecule Injectable Drugs Segment by Type in 2021
    Figure 2. Large Molecule Injectable Drugs Segment by Application in 2021
    Figure 3. Global Large Molecule Injectable Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Large Molecule Injectable Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Large Molecule Injectable Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Large Molecule Injectable Drugs Revenue in 2021
    Figure 8. By Type - Global Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
    Figure 12. US Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
    Figure 24. China Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Biogen Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. AstraZeneca Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Roche Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Sun Pharmaceutical Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Medtronic Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Novartis Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. ​​Baxter Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Amgen Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Pfizer Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Johnson & Johnson Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
64
Frequently Asked Questions
Large Molecule Injectable Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Large Molecule Injectable Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Large Molecule Injectable Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Syphilis Diagnosis Market

Syphilis is a chronic, systemic sexually transmitted disease caused by the leptospira. Read More